FFC#15/2016

Cystic fibrosis modifier genes related to Pseudomonas aeruginosa lung disease

FFC#15/2016

Cystic fibrosis modifier genes related to Pseudomonas aeruginosa lung disease

PRINCIPAL INVESTIGATOR

Alessandra Bragonzi (Unità Infezioni e Fibrosi cistica, Divisione di Immunologia, Trapianti e Malattie Infettive, Istituto Scientifico San Raffaele, Milano)

Partner

Harriet Corvol (St. Antoine Research Center, lnserm U938/UPMC, Cystic Fibrosis Physiopathology and Phenogenomics Laboratory, Paris)

RESEARCHERS

9

CATEGORY

AREA 3 Bronchopulmonary infection

DURATION

2 years

GOAL

€ 45.000 €

RESULTS

This project hypothesizes candidate modifier genes within the identified QTL(Quantitative Trait Locus) in murine models and aims to validate them as risk factors for P. aeruginosa infection and disease severity. Validation of candidate modifier genes was carried out: 1) in model system including gene editing with CRISPR/Cas9 of cell lines; 2) in CF patients cohorts by exploring available BIO-banks. Fourteen protein-coding genes were candidates for involvement in P. aeruginosa pneumonia. Among others, the sphingosine 1-phosphate receptor 1 (S1PR1) ranked as one of the most promising candidates. To translate these results to humans, first, a genotyped cohort (Canadian CF Gene Modifier) with clinical microbiological data for P. aeruginosa infection was used for identification of candidate genes. Genetic-association analysis on the syntenic human locus on chromosome 1 identified two single-nucleotide polymorphisms annotated to the dihydropyrimidine dehydrogenase (DPYD) gene that were significantly associated with age at first P. aeruginosa infection. DPYD encoded a pyrimidine catabolic enzyme and has never been described in infection and inflammation processes. Other CF patients cohorts are under evaluation.


 Pubblications

– Lorè NI, Cigana C, Sipione B et al. “The impact of host genetic background in the Pseudomonas aeruginosa respiratory infections” Mammalian Genome 2018 Jun 12.

Congress abstracts

– Lorè NI, Sipione B, Mott R et al. “Host genetic traits influence the severity of respiratory infections by Pseudomonas
aeruginosa” 30th Annual North American Cystic Fibrosis Conference – Orlando, October 27-29, 2016
– Lorè NI, Sipione B, Mott R et al. “Novel disease models to capture pathological complexity of Pseudomonas aeruginosa respiratory infection “ ECFS 2017 – The 40th European Cystic Fibrosis Conference– Siviglia, June 18-21, 2017
– Lorè NI, Iraqi F, Bragonzi A “Novel genetically-diverse mouse models to unravel the complexity of the lung infections” 2017 ECFS Basic Science Conference – Albufeira 29-1 April, 2017
– Lorè NI, Sipione B, Mott R et al. “Novel disease models to capture pathological complexity of Pseudomonas aeruginosa respiratory infection “ CFF Research Conference – Stevenson, June 18-21, 2017
– Lorè NI, Sipione B, He G et al. “Novel genetically-diverse mouse models to unravel genetic modifiers for Pseudomonas aeruginosa infection” North American Cystic Fibrosis Conference (NACFC), November 2-4, 2017, Indianapolis

OTHER RESULTS

FFC #3/2024

Two molecules are effective in activating Heat Shock Proteins and enhancing the action of CFTR correctors with the F508del mutation in vitro.

FFC#5/2024

Some peptide nucleic acids (PNAs) re-sensitise Pseudomonas aeruginosa to the antibiotic meropenem in vitro and reduce its virulence.

FFC#1/2023

Tezacaftor, one of the components of Kaftrio, induces an accumulation of dihydroceramides both in vitro and in vivo in animal models